Syntis Bio
$33.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Syntis Bio is currently valued at $67.0M as of July 1, 2025. The company has raised a total of $48.4M in funding.
Capital Efficiency
With a capital efficiency ratio of 1.39x, Syntis Bio has achieved a valuation that is 1.39 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
Syntis Bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Syntis Bio Worth in 2025?
As of 2025, Syntis Bio is valued at $67.0M, based on the company's Early Stage VC funding round in July 1, 2025. This valuation positions Syntis Bio as one of the leading private companies in the sector.
Syntis Bio Valuation History
Syntis Bio's funding history demonstrates steady growth and investor confidence.
How Syntis Bio Valuation is Determined
Private company valuations like Syntis Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Syntis Bio Valuation FAQs
Is Syntis Bio profitable?
Syntis Bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Syntis Bio's valuation compare to competitors?
Syntis Bio is valued at $67.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Syntis Bio IPO?
Syntis Bio has not announced plans for an initial public offering. Until an IPO, investors can access Syntis Bio shares through secondary market platforms.